Liraglutide treatment is associated with progression of coronary artery fibrous plaque: a prospective 1-year follow-up study in asymptomatic patients with type 2 diabetes

Abstract Objective The objective of this study was to assess the association between clinically indicated liraglutide treatment and coronary artery plaque progression during 1-year follow-up in asymptomatic diabetes. Methods Patients were divided into a group receiving liraglutide (Lira+) and a grou...

Descrición completa

Detalles Bibliográficos

Principais autores:	Laurits Juhl Heinsen, Gokulan Pararajasingam, Thomas Rueskov Andersen, Søren Auscher, Hussam Mahmoud Sheta, Helle Precht, Kalle Brunebjerg Engdam, Jørgen Hangaard, Jess Lambrechtsen, Filip Krag Knop, Kenneth Egstrup
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-04-01
Series:	BMC Cardiovascular Disorders
Assuntos:	Type 2 diabetes mellitus Coronary atherosclerosis Glucagon-like peptide 1 receptor agonist Liraglutide Coronary computed tomography angiography
Acceso en liña:	https://doi.org/10.1186/s12872-023-03228-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!